Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to “administrative constraints” at the agency. T… [+1864 chars]Read More
Moderna says FDA delayed RSV vaccine approval to end of May CNBC
